Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Join a 42-minute webinar featuring Dr. Sabrina Paganoni from Massachusetts General Hospital and six Patient Advisory Committee members as they explore the critical topic of placebo data retirement in the HEALEY ALS Platform Trial. Discover the significance of retiring placebo data from the first five treatment regimens and understand how this milestone impacts both current participants and future ALS research. Learn about the scientific advantages of contributing placebo data to PRO-ACT, an open access database that accelerates ALS research worldwide. Gain insights from patient advocates about the real-world implications of this data sharing initiative and how it represents a major step forward in collaborative ALS research methodology. Understand the ethical and scientific considerations behind placebo data retirement and its role in optimizing future platform trial designs for ALS treatments.
